---
title: Innovate Research vs PharPoint Research
slug_a: innovate-research
slug_b: pharpoint
site: cro
review_signal_gate: closed
canonical_path: /compare/innovate-research/pharpoint
---

# Innovate Research vs PharPoint Research

Side-by-side profile data from each company listing on this directory.

## Innovate Research

- Profile: [/companies/innovate-research](/companies/innovate-research)

Innovate Research — Indian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.

Services: 11. Modalities: 3. Indications: 0. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)

## PharPoint Research

- Profile: [/companies/pharpoint](/companies/pharpoint)

PharPoint Research — PharPoint is a US-based CRO specializing in Phase I–IV clinical trials with rapid biometrics timelines, delivering database locks within 5 days of last patient visit and topline results in 2 business days.

Services: 9. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)